Microbiome Diversity Through the Lifestages

Published May 2019. As scientific insight into the workings of the human microbiome advances, the whole new universe of targeted manipulation aimed at achieving specific health outcomes opens up. The tool kit for this, which comprises pre, pro, and post-biotics, is expanding.

This report highlights emerging opportunities, such as risk reduction of developing childhood eczema before the child is born, pushing sporting performance to new heights and reaching a triple-figure life expectancy while remaining active and free from disease. It also evaluates consumer satisfaction with currently available life-stage probiotics, to help the industry deliver the most satisfying formulations.


What this report tells you:

  • What the microbiome is and what it does for us, as well as factors that can negatively affect this fluctuating population of microbes and how it has become a therapeutic target.
  • A closer look at the role of the microbiome in the First 1000 Days and its possible role in common complaints like colic and diarrhoea in infants.
  • Probiotic research pertaining to parents pre-conception and how this might have a lifelong impact on the health of the child.
  • Analysis on the role of the microbiome in specific issues relating to young adults including IBS, sporting pursuits and weight management – plus how current product addressing these issues are being received by consumers.
  • A closer look at the ageing microbiome, particularly in relation to active seniors. Here the main health concerns in this population are identified and weighted based on online consumer engagement.
  • Future outlook: what is next for the microbiome and what rising trends businesses should seek to address in new product development.

Quick facts:

  • The composition of the microbiome varies over a lifetime. A microbiome with a high degree of species diversity appears to be protective of disease and therefore microbiome modulation is set to emerge as a major prevention as well as a therapeutic strategy. The precise protocol will necessarily vary, depending on life stage, gender, personal circumstances and individual goals/preferences.
  • Young women are the group most affected by IBS. A reduced microbiome diversity appears to be implicated in the the condition. Consumer satisfaction with probiotic products positioned at IBS sufferers is fairly high, but could still do with some improvement.
  • Young males tend to be hard to reach with health and wellness messages, and our research has shown that their engagement with probiotics is considerably lower than women’s. Sports nutrition products present a viable vehicle, since this category exerts a high appeal over this group. At present, only 2% of the sports nutrition protein powders captured by our research featured probiotic ingredients. We also found that the number of strains employed in sports nutrition products remains very limited.



  • Scope & key findings
  • Why is the microbiome garning interest?
  • The First 100 Days
  • Young adult challenges
    • The gut war: IBS
    • Sporting pursuits
    • Weight management
  • Active seniors
  • Future outlook

Total slides: 42

Got questions about the probiotics market?

We examine the key players, trends and target consumers in over 20 countries, as well as explore how Lumina can help you form a fact-based business strategy.